Shopping Cart
Remove All
Your shopping cart is currently empty
Codrituzumab-MMAE
Copy Product Info
😃Good
Synonyms:
Catalog No. T9901A-2421 Copy Product Info
😃Good
Codrituzumab-MMAE is an antibody-drug conjugate (ADC) targeting GPC3/Glypican-3, with Codrituzumab as the antibody component and MMAE as the payload. It can be used for oncology and ADC drug development research.
Codrituzumab-MMAE
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Antibody Information
Storage & Solubility Information
| Description | Codrituzumab-MMAE is an antibody-drug conjugate (ADC) targeting GPC3/Glypican-3, with Codrituzumab as the antibody component and MMAE as the payload. It can be used for oncology and ADC drug development research. |
| Reactivity | Human |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | MMAE |
| Gene ID | |
| Uniprot ID | |
| Target | GPC3/Glypican-3 |
| Isotype | IgG1 |
| Storage | -20°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags:
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.